(Q50778699)

19 March 2018

title

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. (English)

1 reference

19 March 2018

0 references

1 reference

Garry L Morefield

1

1 reference

19 March 2018

Anna Sokolovska

2

1 reference

19 March 2018

Dongping Jiang

3

1 reference

19 March 2018

Harm HogenEsch

4

1 reference

19 March 2018

J Paul Robinson

5

1 reference

19 March 2018

Stanley L Hem

6

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 February 2005

1 reference

19 March 2018

published in

Vaccine

1 reference

19 March 2018

volume

23

1 reference

19 March 2018

issue

13

1 reference

19 March 2018

page(s)

1588-1595

1 reference

19 March 2018

Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Effect of pH on the Elution of Model Antigens from Aluminum-Containing Adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Primary structure of bovine s1 casein. Complete sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Aluminum compounds used as adjuvants in vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Measuring the surface area of aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

Distribution of adsorbed antigen in mono-valent and combination vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.07.050

10.1016/J.VACCINE.2004.07.050

7 January 2021

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018